On February 14, 2019 CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody therapeutic technology platform, repored full-year 2018 financial results on Wednesday, February 27, 2019, after the close of U.S. markets (Press release, CytomX Therapeutics, FEB 14, 2019, View Sourcenews-releases/news-release-details/cytomx-therapeutics-announce-full-year-2018-financial-results" target="_blank" title="View Sourcenews-releases/news-release-details/cytomx-therapeutics-announce-full-year-2018-financial-results" rel="nofollow">View Source [SID1234533349]). Following the announcement, the company will host a conference call beginning at 5:00 p.m. ET to discuss its results.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Participants may access the live audio webcast of the teleconference from the "Investors & News" section of CytomX’s website at View Source . Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software.
Audio Conference Call:
U.S. Dial-in Number: (877) 809-6037
International Dial-in Number: (615) 247-0221
Conference ID: 3748238
An archived webcast replay will be available on the Company’s website from February 27, 2019, until March 6, 2019.
CytomX Therapeutics’ 2019 Research and Development Day
CytomX plans to host a Research and Development Day on February 26, 2019 from 8:00 a.m. – 11:30 a.m. ET in New York City.
The event will be webcast live under the "Investors & News" section of CytomX’s website at View Sourceevents-and-presentations. Please connect to the webcast several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary. An archived webcast replay will be available on the Company’s website for 90 days following the event.
Institutional investors and equity analysts seeking information on or registration for the live event in New York City please contact Chris Keenan at [email protected].